Through
12/13
Cancer Research
Improved gene editing method could power future cell and gene therapies
Improved gene editing method could power future cell and gene therapies
A new technique based on special cell-penetrating peptides promises advantages over current methods for editing the genomes of primary cells, such as patients’ T cells.
Why Penn research powers many FDA-approved treatments
Why Penn research powers many FDA-approved treatments
Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications.
Running and walking for oral cancer awareness
Running and walking for oral cancer awareness
In a student-led effort, the School of Dental Medicine hosted the Oral Cancer Walk & 5K. The event has been an annual tradition since 2009, offering both a community celebration and a venue for discussing oral cancer prevention and detection.
More cancers may be treated with drugs than previously believed
More cancers may be treated with drugs than previously believed
Using a Penn-designed neural network called PocketMiner, a Penn Medicine research team has identified hidden protein pockets that can provide new opportunities for cancer drugs to bind to.
A potential strategy to improve T cell therapy in solid tumors
A potential strategy to improve T cell therapy in solid tumors
A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors.
A moment for men’s health
A moment for men’s health
Since 2012, the Basser Center for BRCA at Penn Medicine’s Abramson Cancer Center has been advancing lifesaving therapies and raising awareness of the risks faced by individuals with BRCA gene mutations.
Can we intercept cancer?
Can we intercept cancer?
Penn researchers are developing new ways to detect and “intercept” cancer from every angle, including basic science to understand the molecular changes that lead to cancer and developing new methods for finding it.
New insights into the mechanisms of tumor growth
New insights into the mechanisms of tumor growth
A team of researchers led by the School of Arts & Science’s Wei Guo characterize the molecular pathways that play a major role in tumorigenesis, findings that could lead to better diagnostic tools for cancer and new targeted therapies.
From a small town in Lebanon to cancer research
From a small town in Lebanon to cancer research
When Mayassa Bou-Dargham, a postdoctoral fellow in Penn’s Abramson Family Cancer Research Institute received a pilot project grant, a banner was hung in her Lebanese hometown. Getting there took years of determination, self-confidence and, in small part, fate.
How one doctor-patient relationship could change how women are treated for gynecologic cancers
How one doctor-patient relationship could change how women are treated for gynecologic cancers
In appreciation for her cancer treatment team led by Neil Taunk, patient Dalia Jakas established a fund to empower Taunk’s research into how treatment can be improved for uterine cancers like the one she experienced.
In the News
Forbes
Carl June: 2024 will be seen as a breakthrough year for brain cancer
Carl June of the Perelman School of Medicine shares five insights on using CAR T cell therapy to combat cancer, featuring remarks from Bruce Levine.
FULL STORY →
Philadelphia Inquirer
Penn plans to build a proton center for cancer treatment at Presbyterian Medical Center
Penn Medicine will build its fourth proton beam center for cancer treatment at Penn Presbyterian Medical Center in University City.
FULL STORY →
PhillyVoice
Double mastectomies do not improve breast cancer survival likelihood for most women, study finds
Angela DeMichele of the Perelman School of Medicine says that chemotherapy and hormonal therapies are important for combating breast cancer because they’re designed to kill spreading cells.
FULL STORY →
The New York Times
Breast cancer survival not boosted by double mastectomy, study says
Angela DeMichele of the Perelman School of Medicine comments on a study which found that breast cancer survival is not boosted by a double mastectomy.
FULL STORY →
Today
How did Shannen Doherty die? What to know about ‘90210’ star’s cause of death
According to Penn Medicine, there is no known cure for metastatic breast cancer.
FULL STORY →
Stat
New immunotherapy combination could ‘change the landscape’ of cancer treatment
A study by Andy Minn and postdoc Divij Mathew of the Perelman School of Medicine and colleagues found that a combination checkpoint inhibitor therapy benefited patients with lung cancer.
FULL STORY →